eujobs.coEU jobs in brussels
Post a JobHeadhunter

MedTech Europe

Acronym: MTE

General Information

Identification Code: 433743725252-26
Website: [object Object]
Entity Form: AISBL
Registration Category: Trade and business associations
Registration Date: 12/26/2016
Last Update: 2/7/2024
EP Accredited Number: 1

Mission & Interests

Goals: MedTech Europe is the European trade association representing the medical technology manufacturers that produce diagnostics, medical devices and digital health solutions in Europe. MedTech Europe's mission is to make safe and innovative medical technology available to more people. MedTech Europe aims to: * promote the value and contribution of the medical technology industry * raise awareness about the role that innovative medical technologies play in providing solutions to Europe’s ever-growing healthcare needs * anticipate and respond to new business trends * develop scientific expertise on questions of economic, medical and technical nature related to the medical technology industry * collect, develop and communicate reliable data on a wide variety of issues to its members * provide services, support and information that add value to our members * encourage the contribution of the medical technology industry to EU industrial competitiveness and sustainable healthcare systems
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
  • Budget
  • Business and industry
  • Communication
  • Competition
  • Consumers
  • Digital economy and society
  • Economy, finance and the euro
  • Employment and social affairs
  • Environment
  • Institutional affairs
  • Public health
  • Regional policy
  • Research and innovation
  • Single market
  • Taxation
  • Trade
Levels of Interest:
  • european

Activities

Main EU Legislative Proposals: * Internal market legislation and any other legislation which impacts upon medical technologies * Files under the responsibility of the DG SANTE, DG GROW, DG RTD, DG ENV, DG CNECT, DG JUST, DG TRADE, DG TAXUD and DG NEAR with particular focus on health, medical devices and IVDs, digital health and Innovation * Regulation (EU) 2017/746 on in vitro diagnostic medical devices and Regulation (EU) 2017/745 on medical devices * Blood, tissues and cells legislation * Animal by-products legislation * The General Data Protection Regulation (EU) 2016/679 * Late payments directive * Policies, Initiatives related to Antimicrobial Resistance (AMR) and Healthcare-Associated Infections (HAIs) and Non Communicable diseases (NCD) * Regulation 2021/2282 on Health Technology Assessment* Cross-Border Health Care * Health system performance assessments / EU semester * Environmental regulations and their implementation (e.g., REACH Regulation, CLP Regulation, RoHS Directive,POPs and Biocidal Products Regulation, Fluorinated Greenhouse Gases Regulation) * The European Green Deal, in particular the Chemicals Strategy for Sustainability and initiatives under the Circular Economy Action Plan to revise the Batteries Legislation, the Packaging and Packaging Waste Llegislation, the Waste Framework and WEEE Directives and set up a Framework Regulation for more Ssustainable Products (Ecodesign Regulation) and a Regulation for Product and Business Environmental Footprint * Artificial intelligence Act * Data Act *Cyber Resilience Act * Directive on measures for a high common level of cybersecurity across the Union *(NIS Directive 2) * Representative Action Directive ("Collective Redress") * Product Liability Directive * AI Liability Directive * Withdrawal of the United Kingdom from the European Union * Bilateral and multilateral trade agreements * Customs procedures and tariffs * Resolution of technical barriers to trade *COUNCIL REGULATION establishing the Joint Undertakings under Horizon Europe and repealing Regulations (EC) No 219/2007, (EU) No 557/2014, (EU) No 558/2014, (EU) No 559/2014, (EU) No 560/2014, (EU) No 561/2014 and (EU) No 642/2014 *Pharmaceutical strategy for Europe *European Health Union * Regulation for a European Health Data Space *Corporate Sustainability Due Diligence Directive *Critical Raw Materials Act
EU Supported Forums and Platforms: 13 - Annex XVI #X03565/2#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100252 #OBSERVER #C#Industry12 - Nomenclature#X03565/1#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100117 #OBSERVER #C#IndustryMedical Device Coordination Group#X03565#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3565 #OBSERVER #C#Industry03 - Clinical Investigation and Evaluation (CIE)#X03565/5#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100600 #OBSERVER #C#Industry02 - Standards#X03565/4#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100599 #OBSERVER #C#Industry11 - In vitro Diagnostic Medical Devices (IVD)#X03565/12#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100608 #OBSERVER #C#IndustryeHealth Stakeholder Group#E02769#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=2769 #MEMBER #C#IndustryCommission expert group "Industrial Forum"#E03743#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3743 #MEMBER #C#Industry#SMEsAntimicrobial Resistance One Health Network#E03853#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3853 #MEMBER #C#Industry04 - Post-Market Surveillance and Vigilance (PMSV)#X03565/6#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100601 #OBSERVER #C#Industry09 - Unique Device Identification (UDI)#X03565/10#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100606 #OBSERVER #C#Industry06 - Borderline and Classification (B&C)#X03565/8#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100603 #OBSERVER #C#Industry10 - International Matters#X03565/11#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100607 #OBSERVER #C#Industry08 - EUDAMED#X03565/13#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100886 #OBSERVER #C#Industry07 - New Technologies#X03565/9#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100604 #OBSERVER #C#Industry
Inter-institutional or Unofficial Groupings: Cancer,Climate change, biodiversity and sustainable development

Head Office

Address: 40 rue Joseph II
Post Code: 1000
City: Brussels
Country: BELGIUM
Phone: [object Object]

EU Office

Address: 40 rue Joseph II
Post Code: 1000
City: Brussels
Country: BELGIUM
Phone: [object Object]

Financial Data

New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Complementary Information: Our cost is estimated @1.6 million. It accounts for: * the staff cost (a prorata 12.5% or 25%) of the 16 FTE involved. * the admin cost linked to those 16 FTE * the operational expenses * the outsourced activities (consultants) e.g. Ogilvy, Incisive, HLC,...

Membership Information

Members10 Percent: 8
Members25 Percent: 8
Members50 Percent: 0
Members75 Percent: 0
Members: 16
Members F T E: 2.799999952316284
Info Members: A total of 16 persons are involved in activities covered by the Register. I have adapted the percentages per individuals (not the total number of persons) so we now have 8 people (instead of 2 in our previous submission) working 10% of their time on those type of activities We have included the following persons: 1 CEO @ 10% 4 FTE (1@25% and 3@10%) from our regulatory team (mainly involved on MDR and IVDR) 5 FTE (3@25% and 2@10%) from our external affairs team 2 FTE (2@10%) from our Legal team 1 FTE (@25%) from our digital team 2 FTE (2@25%) from our sustainability team 1 FTE (@25%) from our international department

Structure

Structure Type: Structure
Is Member Of: Please see on: https://www.medtecheurope.org/about-us/members/
Organisation Members: *AMR One Health Network:EC led multistakeholder platform to deal with the cross-border health threat of AMR *AMR Patient Group: the AMR Patient Group is an initiative of Health First Europe and is comprised of national patient associations from across Europe. The group aims to address the gap in awareness at the patient-level about the danger of antibiotic misuse and the lack of effective infection prevention measures *AP4HE:an intersectoral initiative that brings together a diverse group of NGOs, think-tanks, associations, companies, and individuals *Data saves lives:A multi-stakeholder initiative with the aim of raising wider patient and public awareness about the importance of health data *EFLM: it connects National Societies of Clinical Chemistry and Laboratory Medicine and creates a platform for all European “Specialists in Laboratory Medicine *ESAE: The leading European organisation bringing together Association professionals *European Internet Forum: MEP-led network of digital policy stakeholders and a neutral, transparent and non-partisan platform to better understand the Internet and its foreseeable impact on Europe's economy, society and governance *European Policy Center:an independent, not-for-profit think tank dedicated to fostering European integration through analysis and debate *Friends of Europe: A think tank that supports a multilateral world in which all levels of governance, the private and civil society sectors, as well as citizens, cooperate to solve common challenges *GMTA: The Global Medical Technology Alliance (GMTA) member associations represent companies that produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. Our represented companies produce nearly 85 percent of the health care technology purchased and utilized annually around the world. *HTA Stakeholder Network: Stakeholder organisations with an interest in Union cooperation on HTA, including patient associations, consumer organisations, health technology developer associations, health professional organisations and other relevant non-governmental organisations in the field of health, including clinical and learned societies.